AstraZeneca
The Global Development Medical Director (Late Phase CVRM) leads late-phase clinical development for cardiovascular, renal, and metabolic indications (including diabetes, obesity and NASH/MASH), aligning scientific strategy to improve patient outcomes. The role ensures design, conduct, interpretation and reporting of clinical trials so data support benefit/risk, labeling and market access globally. The position adheres to high ethical standards and regulatory/GCP requirements while working cross-functionally and with external stakeholders.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Clinical Pharmacologist/Clinical Research Physician
Eli Lilly and Company
Clinical Development Operations Lead
Digital Biology
(Lead) Clinical Director
Roche
Senior Medical Director, Oncology Early Development
AbbVie
Medical Director, Clinical Development, Obesity
Regeneron Pharmaceuticals
Senior Project Manager
IQVIA